Shanghai Chaoli'an Technology Co., Ltd. announced that it has raised CNY 43 million in an equity round of funding on June 7, 2023. The transaction will include participation from new investor, Qingdao Haier Biomedical Co., Ltd, for 54.31% stake in the company. The transaction will be closed in the tranches, first tranche for CNY 18 million, second and third for CNY 15 and CNY 10 million respectively.

The transaction has been approved by the shareholders of the company in the the thirteenth meeting of the second board of supervisors of the company.